A Study to Test How Well Multiple Doses of BI 765423 Are Tolerated by Healthy Men
Clinical trial NCT06232252 · COMPLETED
Trial details
- NCT number
- NCT06232252
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-06
- Primary completion
- 2025-04-25
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.